Showing results (331-340 of 479) with videos related to
Sort By:
Pageof 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional studyD F Bajorin, M F Sarosdy, D G Pfister, et al.Head & Neck|May 1, 1997
Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongueL B Harrison, M J Zelefsky, D G Pfister, et al.Cancers of the Head & Neck|May 17, 2019
Employment and return to work following chemoradiation in patient with HPV-related oropharyngeal cancerShrujal S Baxi, Talya Salz, Han Xiao, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2008
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancerSeng Chuan Ong, Heiko Schöder, Nancy Y Lee, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 2, 2017
[Outcomes of transcutaneous posterior tibial nerve stimulation for overactive bladder in diabetic patients]L Mathieu, B Peyronnet, N Senal, et al.Journal of the National Cancer Institute|March 6, 1991
Genetic analysis as an aid in diagnosis for patients with midline carcinomas of uncertain histologiesR J Motzer, E Rodriguez, V E Reuter, et al.Oral Oncology|May 8, 2025
Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancerJennifer R Cracchiolo, Michael T Starc, Richard J Wong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibitionRowan T Chlebowski, Nananda Col, Eric P Winer, et al.Cancer|March 10, 2001
The Collection of Indirect and Nonmedical Direct Costs (COIN) form: a new tool for collecting the invisible costs of androgen independent prostate carcinomaE J Sherman, D G Pfister, H S Ruchlin, et al.Cancer|March 3, 2015
Treatment-related toxicities in older adults with head and neck cancer: A population-based analysisCaitriona B O'Neill, Shrujal S Baxi, Coral L Atoria, et al.Pageof 48